306 related articles for article (PubMed ID: 34887360)
1. lncRNA CASC7 regulates pathological progression of ox-LDL-stimulated atherosclerotic cell models via sponging miR-21 and regulating PI3K/Akt and TLR4/NF-κB signaling pathways.
Pei X; Wen Y; Cui F; Yang Z; Xie Z
Aging (Albany NY); 2021 Dec; 13(23):25408-25425. PubMed ID: 34887360
[TBL] [Abstract][Full Text] [Related]
2. MiR-217 inhibits apoptosis of atherosclerotic endothelial cells via the TLR4/PI3K/Akt/NF-κB pathway.
Zhang B; Zhang YF; Li R; Zhao L; Qin SG; Pan LF; Gao YX
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12867-12877. PubMed ID: 33378037
[TBL] [Abstract][Full Text] [Related]
3. LncRNA OIP5-AS1 facilitates ox-LDL-induced endothelial cell injury through the miR-98-5p/HMGB1 axis.
Zheng Z; Zhang G; Liang X; Li T
Mol Cell Biochem; 2021 Jan; 476(1):443-455. PubMed ID: 32990894
[TBL] [Abstract][Full Text] [Related]
4. LncRNA TUG1 regulates proliferation and apoptosis by regulating miR-148b/IGF2 axis in ox-LDL-stimulated VSMC and HUVEC.
Wu X; Zheng X; Cheng J; Zhang K; Ma C
Life Sci; 2020 Feb; 243():117287. PubMed ID: 31926240
[TBL] [Abstract][Full Text] [Related]
5. HOTTIP knockdown inhibits cell proliferation and migration via regulating miR-490-3p/HMGB1 axis and PI3K-AKT signaling pathway in ox-LDL-induced VSMCs.
Guo X; Liu Y; Zheng X; Han Y; Cheng J
Life Sci; 2020 May; 248():117445. PubMed ID: 32081664
[TBL] [Abstract][Full Text] [Related]
6. Long Noncoding RNA OIP5-AS1 Contributes to the Progression of Atherosclerosis by Targeting miR-26a-5p Through the AKT/NF-κB Pathway.
Ren M; Wang T; Han Z; Fu P; Liu Z; Ouyang C
J Cardiovasc Pharmacol; 2020 Nov; 76(5):635-644. PubMed ID: 32833899
[TBL] [Abstract][Full Text] [Related]
7. MiR-590 Inhibits Endothelial Cell Apoptosis by Inactivating the TLR4/NF-κB Pathway in Atherosclerosis.
Yang L; Gao C
Yonsei Med J; 2019 Mar; 60(3):298-307. PubMed ID: 30799593
[TBL] [Abstract][Full Text] [Related]
8. Kaempferol alleviates ox-LDL-induced apoptosis by up-regulation of miR-26a-5p via inhibiting TLR4/NF-κB pathway in human endothelial cells.
Zhong X; Zhang L; Li Y; Li P; Li J; Cheng G
Biomed Pharmacother; 2018 Dec; 108():1783-1789. PubMed ID: 30372882
[TBL] [Abstract][Full Text] [Related]
9. LncRNA XIST knockdown ameliorates oxidative low-density lipoprotein-induced endothelial cells injury by targeting miR-204-5p/TLR4.
Lu G; Tian P; Zhu Y; Zuo X; Li X
J Biosci; 2020; 45():. PubMed ID: 32345778
[TBL] [Abstract][Full Text] [Related]
10. Myricetin ameliorates ox-LDL-induced HUVECs apoptosis and inflammation via lncRNA GAS5 upregulating the expression of miR-29a-3p.
Bai Y; Liu X; Chen Q; Chen T; Jiang N; Guo Z
Sci Rep; 2021 Oct; 11(1):19637. PubMed ID: 34608195
[TBL] [Abstract][Full Text] [Related]
11. Myristicin regulates proliferation and apoptosis in oxidized low-density lipoprotein-stimulated human vascular smooth muscle cells and human umbilical vein endothelial cells by regulating the PI3K/Akt/NF-κB signalling pathway.
Luo L; Liang H; Liu L
Pharm Biol; 2022 Dec; 60(1):56-64. PubMed ID: 34905418
[TBL] [Abstract][Full Text] [Related]
12. Notoginsenoside R1 upregulates miR-221-3p expression to alleviate ox-LDL-induced apoptosis, inflammation, and oxidative stress by inhibiting the TLR4/NF-κB pathway in HUVECs.
Zhu L; Gong X; Gong J; Xuan Y; Fu T; Ni S; Xu L; Ji N
Braz J Med Biol Res; 2020; 53(6):e9346. PubMed ID: 32401923
[TBL] [Abstract][Full Text] [Related]
13. MiR-647 promotes proliferation and migration of ox-LDL-treated vascular smooth muscle cells through regulating PTEN/PI3K/AKT pathway.
Xu CX; Xu L; Peng FZ; Cai YL; Wang YG
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):7110-7119. PubMed ID: 31486513
[TBL] [Abstract][Full Text] [Related]
14. LncRNA SNHG16 promoted proliferation and inflammatory response of macrophages through miR-17-5p/NF-κB signaling pathway in patients with atherosclerosis.
An JH; Chen ZY; Ma QL; Wang HJ; Zhang JQ; Shi FW
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8665-8677. PubMed ID: 31646601
[TBL] [Abstract][Full Text] [Related]
15. The suppression of ox-LDL-induced inflammatory response and apoptosis of HUVEC by lncRNA XIAT knockdown via regulating miR-30c-5p/PTEN axis.
Hu WN; Duan ZY; Wang Q; Zhou DH
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7628-7638. PubMed ID: 31539155
[TBL] [Abstract][Full Text] [Related]
16. LncRNA ENST00113 promotes proliferation, survival, and migration by activating PI3K/Akt/mTOR signaling pathway in atherosclerosis.
Yao X; Yan C; Zhang L; Li Y; Wan Q
Medicine (Baltimore); 2018 Apr; 97(16):e0473. PubMed ID: 29668625
[TBL] [Abstract][Full Text] [Related]
17. Insulin inhibits inflammation and promotes atherosclerotic plaque stability via PI3K-Akt pathway activation.
Yan H; Ma Y; Li Y; Zheng X; Lv P; Zhang Y; Li J; Ma M; Zhang L; Li C; Zhang R; Gao F; Wang H; Tao L
Immunol Lett; 2016 Feb; 170():7-14. PubMed ID: 26681144
[TBL] [Abstract][Full Text] [Related]
18. LncRNA-CASC7 enhances corticosteroid sensitivity via inhibiting the PI3K/AKT signaling pathway by targeting miR-21 in severe asthma.
Liu JH; Li C; Zhang CH; Zhang ZH
Pulmonology; 2020; 26(1):18-26. PubMed ID: 31412983
[TBL] [Abstract][Full Text] [Related]
19. MircoRNA-126-5p inhibits apoptosis of endothelial cell in vascular arterial walls via NF-κB/PI3K/AKT/mTOR signaling pathway in atherosclerosis.
Jia W; Liu J; Tian X; Jiang P; Cheng Z; Meng C
J Mol Histol; 2022 Feb; 53(1):51-62. PubMed ID: 34981408
[TBL] [Abstract][Full Text] [Related]
20. LncRNA XIST Promotes Atherosclerosis by Regulating miR-599/TLR4 Axis.
Yang K; Xue Y; Gao X
Inflammation; 2021 Jun; 44(3):965-973. PubMed ID: 33566259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
